BioBoston Consulting

Dealing with FDA Form 483 and Warning Letter Findings | BioBoston Consulting

Learn how to effectively respond to FDA Form 483 and Warning Letters. Discover best practices for compliance, corrective action plans, and maintaining open communication with the FDA..  Food and Drug Administration (FDA) oversee strict regulations over life science companies in the United States, that is why it is necessary to be on top of Food […]

Avoid Common FDA Inspection Pitfalls: Compliance Tips for Life Science Companies 

Discover how life science companies can avoid common FDA inspection pitfalls. Learn about the importance of compliance, internal audits, and the role of compliance consultants.  Common FDA Inspection Pitfalls: How to Avoid Them?  Compliance within the life science industry is a vital part of business operations.  The US FDA is a vital regulatory body for […]

Best Practices in Change Control for mRNA Immunotherapy Manufacturing | BioBoston Consulting

Learn the importance of change control in mRNA immunotherapy manufacturing. Discover best practices for risk assessment, collaboration, and regulatory compliance to ensure product quality and safety. Best Practices in Change Control for mRNA Immunotherapy Manufacturing  Understand the importance of change control for mRNA immunotherapy manufacturing — and best practices for fluent adaptation for  a compliant […]

Your Comprehensive Guide to IND Submission Process | BioBoston Consulting 

Discover the step-by-step roadmap to preparing and submitting your IND application. BioBoston Consulting provides expert guidance to navigate regulatory requirements for successful clinical trials. From Concept to IND Submissions: A Detailed Roadmap to Regulatory Approval  The Investigational New Drug (IND) application is a crucial regulatory submission required to begin clinical trials for pharmaceutical/ biotech/ medical […]

Comprehensive Guide to Biologics License Application (BLA) Submission | BioBoston Consulting

Discover how BioBoston Consulting can streamline your Biologics License Application (BLA) submission process. Our expert team provides regulatory roadmaps, document preparation, quality assurance, and interactive reviews to ensure your success. The BLA Submission Process Explained  A Biologics License Application is an extensive record that contains all the relevant information about the biologic product, its manufacturing […]

Engage with GMP Annual Refreshers: Fun & Effective Training

Discover how GMP annual refreshers can be engaging and enjoyable. Explore interactive formats, real-life case studies, and more! The world of pharmaceuticals, biotechnology, and medical devices moves at a fast pace. Therefore, keep yourself updated on ever-evolving regulations and industry best practices is necessary. Step in the GMP (Good Manufacturing Practice) annual refresher training, a […]

New FDA Guidance on Device Software Functions: Key Changes and Implications | BioBoston Consulting

“Explore the FDA’s updated guidance on content in premarket submissions for device software functions. Learn about risk-based documentation, verification processes, and modern development practices to ensure software safety and efficacy.”  The U.S. Food and Drug Administration (FDA) recently released a new guidance document on premarket submissions for device software functions. The guidance “Content of Premarket […]

Key Differences Between US and EU GMP Regulations

Explore the key differences between US and EU Good Manufacturing Practices (GMP). Understand regulatory frameworks, risk management, documentation, and more to ensure compliance in pharmaceutical manufacturing. The quality, safety, and efficacy of pharmaceutical products are highly regulated by Good Manufacturing Practices (GMPs) throughout the lifecycle of product manufacture. The guidelines establish a set of standards […]